PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIobenguane i-131
Iobenguane i 131
Azedra (iobenguane i 131) is a small molecule pharmaceutical. Iobenguane i 131 was first approved as Iobenguane sulfate i 131 on 1994-03-25.
Download report
Favorite
Drugs Approved for Childhood Cancers
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
adreviewNew Drug Application2024-01-10
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration
Code
IOBENGUANE I-131, AZEDRA, PROGENICS PHARMS INC
2025-07-30ODE-204
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
53 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PheochromocytomaD010673——11———1
Neuroendocrine tumorsD018358EFO_1001901D3A.811———1
ParagangliomaD010235——11———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIobenguane i 131
INNiobenguane (131i)
Description
2-[(3-iodophenyl)methyl]guanidine is an organoiodine compound.
Classification
Small molecule
Drug classiodine-containing contrast media
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
N=C(N)NCc1cccc([131I])c1
Identifiers
PDB—
CAS-ID77679-27-7
RxCUI—
ChEMBL IDCHEMBL1615779
ChEBI ID—
PubChem CID60860
DrugBankDB06704
UNII IDQ461L7AK4R (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,370 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
217 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use